Get started
222

OLIPASS CORPORATION

No trades
See on Supercharts
Overview
Financials
Discussions Technicals Seasonals

244460 fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

OliPass Corp. develops biological products. It offers artificial gene and gene therapy. The company was founded by Shin Chung on November 16, 2006 and is headquartered in Yongin, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

244460 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company